GLP3 - RETA 30mg

PeptiQ Labs provides premium-grade Retatrutide, a next-generation investigational peptide studied for its activity as a triple hormone receptor agonist targeting the GLP-1, GIP, and glucagon receptors. This 30mg formulation is intended for researchers investigating metabolic signaling pathways, energy balance regulation, glucose metabolism, and weight-related endocrine mechanisms in controlled laboratory environments. 

Our Retatrutide is synthesized under rigorous laboratory standards. Each batch undergoes High-Performance Liquid Chromatography (HPLC) verification to ensure a purity of ≥99%, providing consistent and reliable results for peptide research and biochemical analysis. 

Key Specifications

• Active Substance: Retatrutide
• Quantity: 30mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized (Freeze-dried) Peptide Powder

Manufacturer: PeptiQ Labs Storage & Handling

• Lyophilized Form: Store vials in a freezer at -4°F (-20°C) for optimal stability.
• Reconstitution: Reconstitute using bacteriostatic water or sterile saline under appropriate laboratory conditions.
• Post-Reconstitution: The solution is sensitive to light and temperature. Store refrigerated and use promptly, or aliquot and freeze to minimize repeated freeze-thaw cycles.

IMPORTANT RESEARCH DISCLAIMER FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is a chemical research reagent intended strictly for in-vitro laboratory research and analysis. It is not approved by the FDA or any regulatory authority for human or veterinary therapeutic use. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Purchase and use are restricted to qualified researchers and licensed professionals.